Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2872570 | The Annals of Thoracic Surgery | 2014 | 7 Pages |
Abstract
The evidence for using thromboprophylaxis after lung cancer operations is relatively sparse, and the use is based predominantly on clinical consensus. However, the risk of VTE seems to occur predominantly within the initial postoperative period, and subsequently the risk falls. Future research should focus on identifying patients and surgical procedures that increase the risk of VTE. This could be accomplished by large observational studies in addition to randomized controlled trials evaluating different thromboprophylaxis strategies.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Thomas D. MD, PhD, Henrik MD, Søren MD, Anne-Mette MD, PhD, Robin MBChB, Babu MD, Torben B. MD, PhD,